Greeting From Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming”11th Pharmacovigilance 2016” The conference will be held on 1st December 2016, Kohinoor Continental Hotel, Mumbai, India
KEY SPEAKERS:-
JEAN CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia- Pacific, Bayer Healthcare(Singapore)
JESSICA THONGCHAREN, Associate director Pharmacovigilance, Takeda Pharmaceuticals (Singapore)
V.KALAISELVAN, Principal Scientific officer, Indian Pharmacopeia commission, Ministry of health & Family welfare, Govt. of India
SUDHIR PAWAR, Coordinator - ADR monitoring Center at LTMMC & GH, Under Pharmacovigilance Programme Of India (PvPI), Indian Pharmacopeia Commission
ARUN BHATT, Consultant, Clinical Research & Development
BHASWAT CHAKARABORTHY, Senior VP & Chair, Research and Development Core Committee, Cadila
SUTAPA B NEOGI, Additional Professor, Indian Institute of Public health
DEEPTI SANGHAVI, Assistant Manager-Medical Writing, Tata consultancy Services
JAMAL BAIG, Country Head- Pharmacovigilance, Merck
SIDDHARTH DESHPADE, Assistant Professor Department of Clinical Pharmacology, KEM Hospital
ABHAY CHIMANKAR, Head, Global drug safety, Cipla
SANDESH SAWANT, Head, Clinical Operations (India and EM), Wockhardt
ABHAY PHANSALKAR, Head clinical trials, Cipla
GRUPREET SINGH, Head Vendor Management, Drug Safety & Epidemiology, Novartis
MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates
VARSHA NARAYANAN, Head mediacal affairs, Wockhardt
POOJA JADHAV, Manager, Sun PharmaceuticalsPlus many more….
KEY THEMES DISCUSED:-
· Updates - legislation, policies, systems, technology, communication strategies and best practice in PV
· Lessons to learn - Pharmacovigilance Programme of India (PvPI)
· Clinical Trial Safety: Shift from Explanatory to Pragmatic Trials
· Developing Pharmacovigilance into high quality management system and its components
· Integrate digital health initiative to minimize risks and enhance patient safety
· Negotiating Country-Specific annexes and adapting Risk Management Plans (RMPs) to Asia
· Developing a refinement of quality in people, process and technology within your PV system
· Changing landscape of PV technologies
· Assuring certain submission in Patient Support Programs (PSP): Leveraging organizational collaboration to enhance data capture
· Understanding the Indian Medical Association (IMA) good practice guide on risk minimization and prevention of medication errors
· Mobile Apps to enforce Pharmacovigilance and risk minimisation interventions
· Using big data to advance drug safety
· Negotiating the regulatory environment
· Accelerating new medicine introduction in developing world & overcoming challenges
· Be part of a major networking opportunity
WHO SHOULD ATEND:-
Vice Presidents, Directors, CRO’s, Heads and Managers of:
Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and
Clinical Data Management, Clinical Research, Research & Development, Product
Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data
Analysis, Epidemiology project management, Regulatory Affairs and
Compliance, Sales & Marketing, Biotech manufacturers
CONFERENCE BOOKING DETAILS:-
Standard Price (18th October 2016):- 1 or 2 Delegates - (INR 7,000 + Tax (15%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
Group Discounts – 3 or 4 Delegates - (INR 6,500 + Tax (15%) per delegate)
Group Discounts – 5 and above Delegates - (INR 6,000 + Tax (15%) per delegate)
Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + Tax (15%) per delegate)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to – TEL: + 91 44 64536444. Email - sponsor@virtueinsight.com
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming”11th Pharmacovigilance 2016” The conference will be held on 1st December 2016, Kohinoor Continental Hotel, Mumbai, India
KEY SPEAKERS:-
JEAN CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia- Pacific, Bayer Healthcare(Singapore)
JESSICA THONGCHAREN, Associate director Pharmacovigilance, Takeda Pharmaceuticals (Singapore)
V.KALAISELVAN, Principal Scientific officer, Indian Pharmacopeia commission, Ministry of health & Family welfare, Govt. of India
SUDHIR PAWAR, Coordinator - ADR monitoring Center at LTMMC & GH, Under Pharmacovigilance Programme Of India (PvPI), Indian Pharmacopeia Commission
ARUN BHATT, Consultant, Clinical Research & Development
BHASWAT CHAKARABORTHY, Senior VP & Chair, Research and Development Core Committee, Cadila
SUTAPA B NEOGI, Additional Professor, Indian Institute of Public health
DEEPTI SANGHAVI, Assistant Manager-Medical Writing, Tata consultancy Services
JAMAL BAIG, Country Head- Pharmacovigilance, Merck
SIDDHARTH DESHPADE, Assistant Professor Department of Clinical Pharmacology, KEM Hospital
ABHAY CHIMANKAR, Head, Global drug safety, Cipla
SANDESH SAWANT, Head, Clinical Operations (India and EM), Wockhardt
ABHAY PHANSALKAR, Head clinical trials, Cipla
GRUPREET SINGH, Head Vendor Management, Drug Safety & Epidemiology, Novartis
MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates
VARSHA NARAYANAN, Head mediacal affairs, Wockhardt
POOJA JADHAV, Manager, Sun PharmaceuticalsPlus many more….
KEY THEMES DISCUSED:-
· Updates - legislation, policies, systems, technology, communication strategies and best practice in PV
· Lessons to learn - Pharmacovigilance Programme of India (PvPI)
· Clinical Trial Safety: Shift from Explanatory to Pragmatic Trials
· Developing Pharmacovigilance into high quality management system and its components
· Integrate digital health initiative to minimize risks and enhance patient safety
· Negotiating Country-Specific annexes and adapting Risk Management Plans (RMPs) to Asia
· Developing a refinement of quality in people, process and technology within your PV system
· Changing landscape of PV technologies
· Assuring certain submission in Patient Support Programs (PSP): Leveraging organizational collaboration to enhance data capture
· Understanding the Indian Medical Association (IMA) good practice guide on risk minimization and prevention of medication errors
· Mobile Apps to enforce Pharmacovigilance and risk minimisation interventions
· Using big data to advance drug safety
· Negotiating the regulatory environment
· Accelerating new medicine introduction in developing world & overcoming challenges
· Be part of a major networking opportunity
WHO SHOULD ATEND:-
Vice Presidents, Directors, CRO’s, Heads and Managers of:
Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and
Clinical Data Management, Clinical Research, Research & Development, Product
Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data
Analysis, Epidemiology project management, Regulatory Affairs and
Compliance, Sales & Marketing, Biotech manufacturers
CONFERENCE BOOKING DETAILS:-
Standard Price (18th October 2016):- 1 or 2 Delegates - (INR 7,000 + Tax (15%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
Group Discounts – 3 or 4 Delegates - (INR 6,500 + Tax (15%) per delegate)
Group Discounts – 5 and above Delegates - (INR 6,000 + Tax (15%) per delegate)
Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + Tax (15%) per delegate)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to – TEL: + 91 44 64536444. Email - sponsor@virtueinsight.com
